|
№ |
Name of the service |
Unit |
Price KZT |
|
Allergy diagnostics |
|||
|
CDL - Allergens domestic/molecular (А) |
|||
|
71 |
СDL - Domestic/molecular allergens (A) |
1 test |
7 140 |
|
72 |
СDL - Fungal allergens (D) |
1 test |
7 140 |
|
73 |
СDL - Tree allergens (T) |
1 test |
7 140 |
|
74 |
СDL - Domestic dust allergens (H) |
1 test |
7 140 |
|
75 |
СDL - Animal allergens (E) |
1 test |
7 140 |
|
76 |
СDL - Inhalant allergens (IP) |
1 test |
7 140 |
|
77 |
СDL - Drug allergens © |
1 test |
7 140 |
|
78 |
СDL - Insect allergens (I) |
1 test |
7 140 |
|
79 |
СDL - Parasitic allergens (P) |
1 test |
7 140 |
|
80 |
СDL - Food-based allergens (F) |
1 test |
7 140 |
|
81 |
СDL - Musty allergens (M) |
1 test |
7 140 |
|
82 |
СDL - Professional allergens (K) |
1 test |
7 140 |
|
83 |
СDL - Other allergens (O) |
1 test |
7 140 |
|
84 |
СDL - Weed allergens (W) |
1 test |
7 140 |
|
85 |
СDL - Allergens of grasses and grains (G) |
1 test |
7 140 |
|
Biochemical screens |
|||
|
Biochemical blood tests. Protein metabolism |
|||
|
86 |
Albumen |
1 test |
2 550 |
|
87 |
Bence Jones protein in urine |
1 test |
61 115 |
|
88 |
Protein immunotyping (M-gradient) |
1 test |
53 550 |
|
89 |
Creatinine |
1 test |
2 720 |
|
90 |
Uric acid |
1 test |
2 720 |
|
91 |
Urea |
1 test |
2 720 |
|
92 |
Total protein |
1 test |
2 720 |
|
93 |
Blood protein electrophoresis (Protein fractions) |
1 test |
9 860 |
|
Biochemical blood tests. Iron metabolism |
|||
|
94 |
Transferrin |
1 test |
4 675 |
|
95 |
Ferritin |
1 test |
6 290 |
|
96 |
Total Iron-Binding Capacity (TIBS) |
1 test |
5 780 |
|
Biochemical blood tests. Lipoprotein metabolism |
|||
|
97 |
Apolipoprotein A (Apo-A) |
1 test |
5 950 |
|
98 |
Apolipoprotein B (Apo-B) |
1 test |
6 800 |
|
99 |
High density lipoproteins (HDL) |
1 test |
3 995 |
|
100 |
Low-density lipoproteins (LDL) |
1 test |
3 230 |
|
101 |
Triglycerides (TG) |
1 test |
2 720 |
|
102 |
Cholesterol (CS) |
1 test |
2 720 |
|
Biochemical blood tests. Pigment metabolism |
|||
|
103 |
Total bilirubin |
1 test |
3 060 |
|
104 |
Conjugated bilirubin |
1 test |
3 060 |
|
Biochemical blood tests. Carbohydrate metabolism |
|||
|
105 |
Glycosylated hemoglobin (Hemoglobin A1c, HbA1c) |
1 test |
6 290 |
|
106 |
Glucose |
1 test |
2 890 |
|
107 |
Glucose on the glucometer |
1 test |
765 |
|
Biochemical blood tests. Enzymes |
|||
|
108 |
Alanine aminotransferase (ALT) |
1 test |
3 230 |
|
109 |
Alpha amylase |
1 test |
3 400 |
|
110 |
Pancreatic amylase |
1 test |
5 950 |
|
111 |
Aspartate aminotransferase (AST) |
1 test |
3 230 |
|
112 |
Gamma glutamyl transferase (GGTP) |
1 test |
4 335 |
|
113 |
Creatinine kinase-MB fraction (CFK-MB) |
1 test |
4 505 |
|
114 |
Creatine phosphokinase (CPK) |
1 test |
3 230 |
|
115 |
Lactate dehydrogenase (LDH) |
1 test |
3 570 |
|
116 |
Alkaline phosphatase (ALP) |
1 test |
3 060 |
|
117 |
Lipase |
1 test |
4 505 |
|
Biochemical urine tests |
|||
|
118 |
Glucose in a single urine portion |
1 test |
2 465 |
|
119 |
Glucose in daily urine |
1 test |
2 635 |
|
120 |
Urine Ca++ |
1 test |
2 550 |
|
121 |
Urine creatinine |
1 test |
2 210 |
|
122 |
Urine Mg++ |
1 test |
2 210 |
|
123 |
Urine uric acid |
1 test |
2 210 |
|
124 |
Urine urea |
1 test |
2 380 |
|
125 |
Microalbumin complex (Creatinine/albumin ratio) |
1 test |
14 875 |
|
126 |
Relative indices of metabolic disorders (ratio calcium/creatinine, magnesium/creatinine, inorganic phosphorus/creatinine, uric acid/creatinine |
1 test |
7 395 |
|
127 |
Relative index of metabolic disorders (calcium/creatinine ratio) |
1 test |
5 185 |
|
128 |
Relative index of metabolic disorders (magnesium/creatinine ratio) |
1 test |
5 610 |
|
129 |
Relative index of metabolic disorders (inorganic uric acid/creatinine ratio) |
1 test |
4 845 |
|
130 |
Relative index of metabolic disorders (inorganic phosphorus/creatinine ratio) |
1 test |
4 675 |
|
131 |
Rehberg test |
1 test |
5 355 |
|
132 |
Glomerular filtration rate |
1 test |
4 335 |
|
133 |
Urine osmolarity |
1 test |
1 105 |
|
134 |
Urine phosphorus |
1 test |
1 785 |
|
135 |
Urine potassium |
1 test |
1 785 |
|
136 |
Sodium urine |
1 test |
1 785 |
|
137 |
Chloride urine |
1 test |
1 785 |
|
Biochemistry |
|||
|
138 |
Blood osmolarity |
1 test |
2 720 |
|
Immune status |
|||
|
139 |
Immunoglobulin A |
1 test |
6 120 |
|
140 |
Immunoglobulin G |
1 test |
6 120 |
|
141 |
Immunoglobulin M |
1 test |
6 120 |
|
142 |
Complement C3 |
1 test |
5 780 |
|
143 |
Complement C4 |
1 test |
5 780 |
|
Hemostatic system testings |
|||
|
144 |
Thrombocyte aggregation with P2Y (PFA 200 analyzer) |
1 test |
41 650 |
|
145 |
Thrombocyte aggregation with ADF (PFA 200 analyzer) |
1 test |
41 650 |
|
146 |
Thrombocyte aggregation with Epinephrine (PFA 200 analyzer) |
1 test |
39 270 |
|
147 |
Activated partial/batch thromboplastin time (APTT/ABTT) |
1 test |
2 720 |
|
148 |
Antithrombin III (AT-3) |
1 test |
7 565 |
|
149 |
Lupus anticoagulant (Lupus test) |
1 test |
11 305 |
|
150 |
Duke bleeding time |
1 test |
1 785 |
|
151 |
Clotting time according to Sukharev |
1 test |
1 785 |
|
152 |
D-Dimer Exclusion quantification |
1 test |
14 705 |
|
153 |
D-dimer (by turbidimetric immunoassay), quantification |
1 test |
17 850 |
|
154 |
Coagulogram - complex No. 1 (APTT, INR, PT, PTI, fibrinogen, TT) |
1 test |
7 140 |
|
155 |
Coagulogram - complex No. 2 (APTT, INR, PT, PTI, fibrinogen, TT+ SFMC) |
1 test |
9 860 |
|
156 |
International normalized ratio (INR) |
1 test |
3 570 |
|
157 |
Protein С |
1 test |
18 785 |
|
158 |
Prothrombin time (PT) |
1 test |
2 890 |
|
159 |
Prothrombin index (PTI) |
1 test |
2 890 |
|
160 |
Soluble fibrin-monomer complexes (SFMC) |
1 test |
2 720 |
|
161 |
C1 inhibitor |
1 test |
21 420 |
|
162 |
Thrombin time (TT) |
1 test |
2 890 |
|
163 |
Thromboelastogram with heparinase |
1 test |
20 910 |
|
164 |
Thromboelastogram with kaolin |
1 test |
27 710 |
|
165 |
Fibrinogen |
1 test |
2 720 |
|
166 |
INR/PT/Quick value in capillary blood |
1 test |
14 280 |
|
Specific proteins |
|||
|
167 |
Alpha - 1 - antitrypsin |
1 test |
8 585 |
|
168 |
Antistreptolysin O (ASL-O) quantification |
1 test |
5 015 |
|
169 |
Haptoglobin |
1 test |
2 890 |
|
170 |
Myoglobin quantification |
1 test |
3 910 |
|
171 |
Rheumatoid factor (RF), quantification |
1 test |
4 420 |
|
172 |
C-reactive protein (CRP) quantitation |
1 test |
4 335 |
|
173 |
Ceruloplasmin |
1 test |
7 310 |
|
Electrolytes, mineral metabolism |
|||
|
174 |
Antibodies to TSH receptors (anti-TSHr, TSH receptor antibodies, a-rTSH) |
1 test |
15 385 |
|
175 |
Ionized calcium |
1 test |
5 950 |
|
176 |
Serum iron (Fe) |
1 test |
3 230 |
|
177 |
Potassium |
1 test |
1 785 |
|
178 |
Total calcium (Ca) |
1 test |
2 720 |
|
179 |
Acid-base state (ABS) of blood (Blood gases) |
1 test |
9 690 |
|
180 |
Magnesium (Mg) |
1 test |
2 890 |
|
181 |
Copper (Cu) |
1 test |
2 295 |
|
182 |
Sodium |
1 test |
2 720 |
|
183 |
Organic phosphorus (P) |
1 test |
3 060 |
|
184 |
Chlorine |
1 test |
2 720 |
|
185 |
Electrolytes (potassium, sodium, ionized calcium, chlorine) in blood serum |
1 test |
8 075 |
|
186 |
Acid-base state of blood, on a portable analyzer of gases, electrolytes and blood metabolites |
1 test |
17 850 |
|
Hematological tests |
|||
|
187 |
LE-phenomenon (LE - cells, lupus cells) |
1 test |
5 355 |
|
188 |
Blood test for malarial plasmodium using the “thin smear” and “thick smear” method |
1 test |
2 295 |
|
189 |
CBC+DIFF |
1 test |
3 995 |
|
190 |
CBC (short) (without WBC) |
1 test |
2 210 |
|
191 |
Reticulocyte count |
1 test |
2 210 |
|
192 |
Thrombocyte count according to Fonio |
1 test |
2 210 |
|
Immune status |
|||
|
193 |
Indicators of cellular immunity (L/cytes; T-l/cytes-CD3+; T-helper cells-CD3.4+; T-cytotoxic - CD3.8+; B-l/cytes CD3-.19+; Natural killer cells - CD3 -,16,56+) |
1 test |
33 915 |
|
194 |
Phagocytosis (oxygen-independent) |
1 test |
18 785 |
|
Immunology research |
|||
|
Vitamins |
|||
|
195 |
Vitamin D total, 25-OH-VitD |
1 test |
13 090 |
|
196 |
Vitamin D3, 25-OH-VitD3 |
1 test |
12 155 |
|
197 |
Vitamin B12, Cyanocobalamin |
1 test |
7 140 |
|
198 |
Active Vitamin B12, Holotranscobalamin |
1 test |
11 475 |
|
199 |
Folic acid (Folate) |
1 test |
6 460 |
|
Gastropanel BIOHIT |
|||
|
200 |
Immunological characteristics of the gastric mucosa (Gastropanel: pepsinogen I, pepsinogen II, gastrin-17B, gastrin-17S, Anti-Heli |
1 test |
41 055 |
|
Hormones of the pituitary-adrenal system in the blood |
|||
|
201 |
Adrenocorticotropic hormone (ACTH) |
1 test |
8 585 |
|
202 |
Aldosterone |
1 test |
12 155 |
|
203 |
Growth hormone (Somatotropic hormone, hGH) |
1 test |
14 280 |
|
204 |
Dehydroepiandrosterone sulfate (DHEA-s) |
1 test |
8 925 |
|
205 |
Cortisol |
1 test |
7 140 |
|
206 |
Catecholamines (adrenaline, noradrenaline, dopamine) in blood plasma by ELISA |
1 test |
41 055 |
|
207 |
Melatonin in blood serum by ELISA method, quantitative determination |
1 test |
25 925 |
|
Hormones of the pituitary-adrenal system in the urine |
|||
|
208 |
Adrenaline (epinephrine) in blood serum by ELISA method, quantitative determination |
1 test |
25 925 |
|
209 |
Dopamine in blood serum by ELISA method, quantitative determination |
1 test |
25 925 |
|
210 |
Noradrenaline (norepinephrine) in blood serum by ELISA method, quantitative determination |
1 test |
25 925 |
|
211 |
Vanillyl mandelic acid in daily urine (VMA, 24h urine) |
1 test |
9 860 |
|
212 |
Homovanillic acid in daily urine (HVA, 24h urine) |
1 test |
9 860 |
|
213 |
Cortisol in daily urine (Cortisol, 24h urine) |
|
8 755 |
|
Pancreatic hormones |
|||
|
214 |
Insulin |
1 test |
8 075 |
|
215 |
Binding peptide (C-Peptide) |
1 test |
8 585 |
|
Reproductive system hormones |
|||
|
216 |
Anti-Mullerian hormone, AMH, MIS |
1 test |
13 430 |
|
217 |
Sex hormone binding globulin (SHBG) |
1 test |
8 925 |
|
218 |
Luteinizing hormone (LH) |
1 test |
6 290 |
|
219 |
Progesterone |
1 test |
6 290 |
|
220 |
Prolactin |
1 test |
6 290 |
|
221 |
Testosterone |
1 test |
8 075 |
|
222 |
Follicle stimulating hormone (FSH) |
1 test |
5 780 |
|
223 |
Estradiol |
1 test |
5 610 |
|
Thyroid hormones |
|||
|
224 |
Antibodies to thyroglobulin (Anti-Tg) |
1 test |
6 290 |
|
225 |
Antibodies to thyroid peroxidase (Anti-TPO) |
1 test |
6 970 |
|
226 |
Thyroglobulin (Tg) |
1 test |
7 565 |
|
227 |
Thyroid stimulating hormone (TSH) |
1 test |
6 290 |
|
228 |
Total thyroxine (total T4) |
1 test |
5 355 |
|
229 |
Free thyroxine (FT4) |
1 test |
5 780 |
|
230 |
Total triiodothyronine (total T3) |
1 test |
6 545 |
|
231 |
Free triiodothyronine (FT3) |
1 test |
6 460 |
|
Autoimmune pathology diagnostics (EIA, ECLIA) |
|||
|
232 |
Antimitochondrial antibodies M2 subtype (AMA-M2) |
1 test |
13 090 |
|
233 |
Antineutrophil cytoplasmic antibodies screening (ANCA-screen) |
1 test |
13 430 |
|
234 |
Antinuclear antibodies screening (ANA screen) |
1 test |
12 155 |
|
235 |
Antinuclear antibodies screening (ANA-Detect) |
1 test |
12 155 |
|
236 |
Antibodies to GBM in blood serum by ELISA method |
1 test |
14 875 |
|
237 |
Antibodies to beta-2-glycoprotein I (Anti-ß-2 Glycoprotein) |
1 test |
11 985 |
|
238 |
Antibodies to double-stranded DNA (a-dsDNA) |
1 test |
12 155 |
|
239 |
Antibodies to single-stranded DNA (a-ssDNA) |
1 test |
12 155 |
|
240 |
Antibodies to gastric parietal cells (a-Parietal cell IgG) |
1 test |
12 155 |
|
241 |
Antibodies to tissue transglutaminase screening (a-tTG IgA,G) |
1 test |
12 155 |
|
242 |
Antibodies to elastase (Anti-Elastase) |
1 test |
12 155 |
|
243 |
Class A antibodies to Saccharomyces cerevisiae (ASCA IgA) |
1 test |
12 155 |
|
244 |
Class G antibodies to Saccharomyces cerevisiae (ASCA IgG) |
1 test |
12 155 |
|
245 |
Class G antibodies to histones (a-Histone IgG) |
1 test |
13 430 |
|
246 |
Class G antibodies to cardiolipin (A-Cardiolipin IgG) |
1 test |
13 430 |
|
247 |
Class G antibodies to modified citrullinated vimentin (A-MCV IgG) |
1 test |
14 705 |
|
248 |
Class G antiphospholipid antibodies (AFL IgG) |
1 test |
13 260 |
|
249 |
Class M antibodies to cardiolipin (A-Cardiolipin IgM) |
1 test |
13 260 |
|
250 |
Class M antiphospholipid antibodies (AFL IgM) |
1 test |
12 155 |
|
251 |
Anti-Prothrombin screening |
1 test |
12 155 |
|
252 |
Antibodies to insulin (A-insulin) |
1 test |
13 430 |
|
253 |
Total antibodies class A, M, G to cardiolipin, screening (A-Cardiolipin total) |
1 test |
12 155 |
|
254 |
Extractable nuclear antibodies, extensive assay (ENA combi) |
1 test |
38 930 |
|
255 |
Antineutrophil cytoplasmic antibodies, extensive assay (ANCA-combi) |
1 test |
60 350 |
|
256 |
Antinuclear antibodies, extensive analysis (ANA combi) |
1 test |
43 775 |
|
257 |
Antisperm antibodies (ASA) |
1 test |
19 635 |
|
258 |
IgG antibodies to cyclic citrullinated peptide (a-CCP) |
1 test |
27 200 |
|
259 |
Antibodies to insulin in blood serum by ELISA method, quantification |
1 test |
8 925 |
|
260 |
Extractable nuclear antibodies, screening (ENA screen) |
1 test |
11 645 |
|
261 |
"ANA pro" for semi-quantitative determination of IgG antibodies to nuclear and cytoplasmic antigens in human serum and plasma |
1 test |
35 700 |
|
262 |
"ANCA Dot" for the qualitative determination of IgG antibodies to myeloperoxidase (MPO), proteinase 3 (PR-3) and glomerular basement membrane (GBM) in human serum and plasma |
1 test |
41 055 |
|
263 |
"ANA 12 LINE" for the qualitative determination of IgG antibodies to nuclear and cytoplasmic antigens in human serum and plasma |
1 test |
44 625 |
|
264 |
Gliadin – IgG Reagent kit for quantitative enzyme immunoassay (ELISA) for the determination of IgG antibodies to gliadin in blood serum |
1 test |
18 785 |
|
265 |
Gliadin – IgA Reagent kit for enzyme immunoassay (ELISA) for the determination of IgA antibodies to gliadin in blood serum |
1 test |
18 785 |
|
266 |
Anti-Acetylcholine Receptor IgG (ELISA), Serum |
|
49 300 |
|
Autoimmune pathology diagnostics (LIA tests) |
|||
|
267 |
Antibodies in autoimmune vasculitis IMTEC-Vasculitis-LIA (IgG to PR3, MPO and GBM) |
1 test |
46 835 |
|
268 |
Antibodies in autoimmune liver diseases IMTEC-Liver-LIA S (IgG to AMA M2, Sp100, LKM1, gp210, LC1 and SLA) |
1 test |
24 140 |
|
269 |
Antinuclear antibodies ANA-LIA (IgG to nucleosomes, dsDNA, histones, SmD1, U1-snRNP, SS-A/Ro60kD, SS-A/Ro52kD, SS-B/La, Scl70, CENP-B, Jo1, P0) |
1 test |
11 135 |
|
270 |
Antinuclear antibodies ANA-LIA MAXX: IgG to nucleosomes, dsDNA, histones, SmD1, PCNA, P0, SS-A/Ro60 and 52kD, SS–B/La, CENP-B, Scl-70, U1-snRNP, AMA M2, Jo-1, PM-Scl, Mi-2(β), Ku |
1 test |
49 300 |
|
271 |
Antibodies in autoimmune myositis IMTEC-Myositis-LIA (IgG to Jo1, Mi2, PM-Scl, U1-snRNP and Ku) |
1 test |
25 245 |
|
272 |
Antibodies for celiac disease IMTEC-Celiac Disease-LIA S (IgA and IgG to gliadin, tissue transglutaminase) |
1 test |
10 710 |
|
273 |
Antibodies in gastrointestinal diseases Gastro-LIA (IgA and IgG to gliadin, tTG, mannan, PCA, Castle factor) |
1 test |
33 575 |
|
274 |
HepAK 7 Plus Dot — Immunodot Assay for Qualitative Detection of IgG Antibodies to M2, LKM-1, LC-1, SLA, F-Actin, gp210, and sp100 in Human Serum or Plasma |
test |
51 000 |
|
275 |
Anti-Phospholipid 10 Dot (Immunodot), IgG/IgM to Phospholipids and β2-Glycoprotein I, Serum |
test |
110 500 |
|
276 |
ANA 18 Line — Immunodot Assay for Qualitative Detection of Autoantibodies to Nuclear and Cytoplasmic Antigens in Human Serum or Plasma |
test |
62 900 |
|
277 |
Anti-Ganglioside Dot — Immunodot Assay for Qualitative Detection of IgG or IgM Antibodies to Gangliosides in Human Serum |
test |
110 500 |
|
Autoimmune pathology diagnostics using indirect immunofluorescence (inDIF) |
|||
|
278 |
Antikeratin antibodies (AKA) by indirect immunofluorescence (inDIF) |
1 test |
14 790 |
|
279 |
Antineutrophil cytoplasmic antibodies (ANCA) by indirect immunofluorescence (inDIF) |
1 test |
10 880 |
|
280 |
Antinuclear factor on the HEp-2 cell line (ANF) by indirect immunofluorescence (inDIF) |
1 test |
14 790 |
|
281 |
Antibodies to native DNA (a-nDNA) by indirect immunofluorescence (inDIF) |
1 test |
14 790 |
|
282 |
Autoantibodies by the method (nRIF) on a triple substrate (LKM-1, Antibodies to gastric parietal cells, to smooth muscles (F-actin), ANF on the HEp-2 cell line, AMA-M1.9) |
1 test |
14 790 |
|
283 |
cANCA — Reagent Kit for the Detection of IgG Antibodies to Neutrophil Cytoplasmic Antigens (ANCA) in Human Serum by Indirect Immunofluorescence (IIF) |
1 test |
34 000 |
|
284 |
pANCA — Reagent Kit for the Detection of IgG Antibodies to Neutrophil Cytoplasmic Antigens (ANCA) in Human Serum by Indirect Immunofluorescence (IIF) |
1 test |
34 000 |
|
285 |
Triple — Reagent Kit for the Detection of Antibodies (ANA/AMA/ASMA/PCA) in Human Serum by Indirect Immunofluorescence (IIF) |
1 test |
37 400 |
|
286 |
nDNA — Reagent Kit for the Detection of IgG Antibodies to Native DNA in Human Serum |
1 test |
30 600 |
|
287 |
CeliAc — Reagent Kit for the Detection of IgA or IgG Antibodies to Endomysium, Tissue Transglutaminase 2 (tTG2), and Deamidated Gliadin in Human Serum |
1 test |
56 100 |
|
288 |
Anti-Aquaporin-4 — Indirect Immunofluorescence (IIF) Reagent Kit for the Detection of Antibodies to Aquaporin-4 in Human Serum |
1 test |
68 000 |
|
289 |
Anti-MOG — Immunofluorescence Assay for the Detection of Antibodies to Myelin Oligodendrocyte Glycoprotein (MOG) in Human Serum |
1 test |
51 000 |
|
Immune status |
|||
|
290 |
Alpha interferon in the blood |
1 test |
14 280 |
|
291 |
Gamma interferon in the blood |
1 test |
14 280 |
|
292 |
Secretory immunoglobulin A in blood serum (sIgA) |
1 test |
8 585 |
|
293 |
Total Immunoglobulin E (total IgE) |
1 test |
9 520 |
|
294 |
Immunophenotyping of HLA B27 in blood using flow cytometry |
1 test |
46 750 |
|
295 |
Interleukin-10 |
1 test |
11 645 |
|
296 |
Interleukin-2 |
1 test |
14 280 |
|
297 |
Interleukin-6 |
1 test |
17 340 |
|
298 |
Interleukin-8 |
1 test |
11 645 |
|
299 |
Interleukin - 13 (IL-13) in serum and blood plasma |
1 test |
31 280 |
|
300 |
Interleukin - 3 (IL-3) in serum and blood plasma |
1 test |
55 335 |
|
301 |
Interleukin - 5 (IL-5) in serum and blood plasma |
1 test |
31 280 |
|
302 |
Interleukin - 1 beta (IL-1-beta, IL-1-β) in human biological fluids and culture media by ELISA method, quantitation |
1 test |
15 725 |
|
303 |
Interleukin - 13 (IL-13, IL-13) in blood serum by ELISA method, quantitation |
1 test |
17 000 |
|
304 |
Interleukin - 18 (IL-18, IL-18) in blood serum by ELISA method, quantitation |
1 test |
13 600 |
|
305 |
Interleukin - 3 (IL-3, IL-3) in blood serum by ELISA method, quantitation |
1 test |
17 000 |
|
306 |
Interleukin - 4 (IL-4, IL-4) in blood serum by ELISA method, quantitation |
1 test |
13 940 |
|
307 |
Interleukin - 5 (IL-5, IL-5) in blood serum by ELISA method, quantitation |
1 test |
17 000 |
|
308 |
Eosinophil cationic protein (ECP) |
1 test |
16 065 |
|
309 |
Tryptase |
1 test |
13 940 |
|
Serological markers of coronavirus infection SARS-CoV-2 (COVID-19, 2019-nCoV) |
|||
|
310 |
IgM antibodies to SARS-CoV-2 (qualitative) |
1 test |
7 735 |
|
311 |
IgG antibodies to SARS-CoV-2 (qualitative) |
1 test |
7 820 |
|
312 |
nCoV antibodies - Nab (post-vaccination, quantitative) |
1 test |
8 925 |
|
313 |
Immunoglobulin G to SARS-CoV-2 (quantitative) |
1 test |
8 925 |
|
314 |
Immunoglobulin M to SARS-CoV-2 (quantitative) |
1 test |
10 710 |
|
315 |
IgG/IgM antibodies to SARS-CoV-2 (Rapid test) (qualitative) |
1 test |
11 645 |
|
316 |
Sars-CoV-2 specific antigen (rapid test) (qualitative) |
1 test |
9 690 |
|
Drug monitoring |
|||
|
317 |
Tacrolimus in blood serum by immunochemiluminescence |
1 test |
17 170 |
|
Markers of sepsis |
|||
|
318 |
Procalcitonin, PCT (quantitation by enzyme immunoassay) |
1 test |
17 850 |
|
319 |
Procalcitonin, PCT (quantitation by immunofluorescence method) |
1 test |
15 555 |
|
Bone metabolism |
|||
|
320 |
Osteocalcin (N-MID Osteocalcin) |
1 test |
10 710 |
|
321 |
Parathyroid hormone (PTH) |
1 test |
10 200 |
|
322 |
Pyrilinks-D (DPD) |
1 test |
6 460 |
|
Tumor markers |
|||
|
323 |
Alpha 1-fetoprotein (AFP) |
1 test |
6 460 |
|
324 |
Squamous cell carcinoma antigen (SCC-Ag) |
1 test |
6 970 |
|
325 |
Calcitonin |
1 test |
15 215 |
|
326 |
Neuron - specific enolase (NSE, NSE) in blood serum by immunochemiluminescence |
1 test |
10 710 |
|
327 |
Progastrin releasing peptide (ProGRP) |
1 test |
9 520 |
|
328 |
Prostate-specific antigen total (PSA total, PSA total) |
1 test |
5 780 |
|
329 |
Prostate-specific antigen free (PSA free) |
1 test |
6 290 |
|
330 |
Carcinoembryonic antigen (CEA, CEA) |
1 test |
6 630 |
|
331 |
Cancer antigen 72-4 (CA 72-4) |
1 test |
11 645 |
|
332 |
Cancer antigen 125 (CA 125) |
1 test |
7 565 |
|
333 |
Cancer antigen 15-3 (CA 15-3) |
1 test |
6 970 |
|
334 |
Cancer antigen 19-9 (CA 19-9) |
1 test |
7 565 |
|
335 |
Cancer antigen 242 (CA 242) |
1 test |
14 705 |
|
336 |
Tumor necrosis factor-alpha (TNF-α, α-TNF) |
1 test |
9 860 |
|
337 |
Cytokeratin fragment 19 (Cyfra21-1) |
1 test |
9 860 |
|
338 |
Human chorionic gonadotropin intact + beta subunit (HCG+beta) |
1 test |
9 860 |
|
339 |
Total human chorionic gonadotropin in urine (HCG urine) |
1 test |
8 075 |
|
340 |
Total human chorionic gonadotropin (HCG) |
1 test |
4 250 |
|
341 |
Human epididymal protein 4 (HE4) |
1 test |
11 645 |
|
Other tests |
|||
|
342 |
Homocysteine (Hcy-SH) |
1 test |
11 900 |
|
343 |
Erythropoietin (EPO) |
1 test |
7 735 |
|
344 |
Pancreatic elastase content in feces |
1 test |
26 775 |
|
Serological markers of brucellosis |
|||
|
345 |
Class A antibodies to the causative agent of brucellosis |
1 test |
7 140 |
|
346 |
Class G antibodies to the causative agent of brucellosis |
1 test |
7 140 |
|
347 |
Class M antibodies to the causative agent of brucellosis |
1 test |
7 140 |
|
Serological markers of viral hepatitis D |
|||
|
348 |
Total class M, G antibodies to hepatitis D virus (a-HDV total) |
1 test |
5 355 |
|
Serological markers of viral hepatitis A |
|||
|
349 |
Class M antibodies to hepatitis A virus (a-HAV IgM) |
1 test |
4 335 |
|
Serological markers of viral hepatitis B |
|||
|
350 |
Hepatitis B virus "e" antigen (HBeAg) |
1 test |
4 590 |
|
351 |
Class G antibodies to the “e” antigen of the hepatitis B virus (a-HBeAg IgG) |
1 test |
4 165 |
|
352 |
Antibodies class G to the nuclear antigen of the hepatitis B virus (a-HBcAg IgG) |
1 test |
4 845 |
|
353 |
Antibodies class M to the nuclear antigen of the hepatitis B virus (a-HBcAg IgM) |
1 test |
4 675 |
|
354 |
Hepatitis B surface antigen (HBsAg, Australian antigen) |
1 test |
4 335 |
|
355 |
Total antibodies class M, G to the “e” antigen of the hepatitis B virus (a-HBeAg total) |
1 test |
4 675 |
|
356 |
Total antibodies class M, G to the surface antigen of the hepatitis B virus (a-HBsAg total) |
1 test |
5 185 |
|
357 |
Total antibodies class M, G to the nuclear antigen of the hepatitis B virus (a-HBcAg total) |
1 test |
5 780 |
|
358 |
НBsAg, Rapid test (Hepatitis B surface antigen, qualitation) |
1 test |
3 230 |
|
Serological markers of viral hepatitis C |
|||
|
359 |
Hepatitis C virus antigen (HCV Ag) |
1 test |
15 215 |
|
360 |
Antibodies class M to hepatitis C virus (HCV IgM) |
1 test |
6 290 |
|
361 |
Total antibodies class M, G to hepatitis C virus (a-HCV total) |
1 test |
5 185 |
|
362 |
a-HCV, Rapid test (Specific antibodies to hepatitis C virus, qualitation) |
1 test |
3 400 |
|
Serological markers of HIV infection |
|||
|
363 |
HIV p24 antigen and antibodies to human immunodeficiency virus types 1, 2 (HIV-1/2, HIV-1/2) |
1 test |
5 355 |
|
364 |
Immunochromatic rapid test of the third generation for the determination of antibodies to human immunodeficiency virus types 1 and 2 (a-HIV-1/2) |
1 test |
3 570 |
|
365 |
Express test for determining the free antigen HIV-1 p24 antibodies and antibodies to human immunodeficiency virus types 1 and 2 (HIV-1 and HIV-2) |
1 test |
5 780 |
|
366 |
ELISA for the presence of antibodies to the human immunodeficiency virus (HIV, AIDS center) |
1 test |
4 505 |
|
Serological markers of herpes infection |
|||
|
367 |
Class G antibodies to herpes simplex virus type 8 (HSV-8-IgG) |
1 test |
4 845 |
|
368 |
Class G antibodies to herpes simplex virus types 1 and 2 (HSV-1,2-IgG) |
1 test |
5 355 |
|
369 |
Class G antibodies to herpes simplex virus type 1 (HSV-1-IgG) |
1 test |
3 910 |
|
370 |
Class G antibodies to herpes simplex virus type 2 (HSV-2-IgG) |
1 test |
5 015 |
|
371 |
Antibodies class G to herpes simplex virus type 6, (HHV-6-IgG) |
1 test |
5 355 |
|
372 |
Class M antibodies to herpes simplex virus types 1 and 2 (HSV-1,2-IgM) |
1 test |
5 015 |
|
373 |
Class M antibodies to herpes simplex virus type 2 (HSV-2-IgM) |
1 test |
5 950 |
|
374 |
Antibodies class M to herpes simplex virus type 1 (HSV-1-IgM) |
1 test |
4 505 |
|
375 |
Avidity index of class G antibodies to herpes simplex virus types 1 and 2 (HSV–1,2-IgG–Avidity) |
1 test |
5 610 |
|
376 |
Avidity index of class G antibodies to herpes simplex virus type 2 (HSV–2-IgG–Avidity) |
1 test |
5 610 |
|
Serological markers of infectious mononucleosis |
|||
|
377 |
Class G antibodies to Epstein-Barr virus early antigen (EBV-EA IgG) |
1 test |
5 780 |
|
378 |
Class G antibodies to Epstein-Barr virus nuclear antigen (EBV-NA IgG) |
1 test |
5 780 |
|
379 |
Class G antibodies to Epstein-Barr virus capsid antigen (EBV-VCA IgG) |
1 test |
5 780 |
|
380 |
Antibodies class M to Epstein-Barr virus capsid antigen (EBV-VCA IgM) |
1 test |
5 780 |
|
381 |
Index of avidity of class G antibodies to the capsid antigen of the Epstein-Barr virus (EBV-VCA IgG-Avidity) |
1 test |
6 290 |
|
Serological markers of rubella |
|||
|
382 |
Class G antibodies to rubella virus (Rubella IgG) |
1 test |
4 675 |
|
383 |
Class M antibodies to rubella virus (Rubella IgM) |
1 test |
5 015 |
|
384 |
Avidity index of class G antibodies to rubella virus (Rubella IgG-Avidity) |
1 test |
5 780 |
|
Serological markers of listeriosis |
|||
|
385 |
Class G antibodies to Listeria monocytogenes |
1 test |
3 995 |
|
Serological markers of cytomegalovirus infection |
|||
|
386 |
Antibodies of class G and M to the immediate early protein of cytomegalovirus (CMV-IEA-IgG/M) |
1 test |
6 460 |
|
387 |
Antibodies class G to cytomegalovirus (CMV IgG) |
1 test |
6 630 |
|
388 |
Antibodies class M to cytomegalovirus (CMV IgM) |
1 test |
6 460 |
|
389 |
Index of avidity of class G antibodies to cytomegalovirus (CMV-IgG-Avidity) |
1 test |
6 290 |
|
Serological markers. Antibodies to protozoa, parasites and fungi |
|||
|
390 |
Class G antibodies to fungi of the genus Candida albicans (Candida albicans IgG) |
1 test |
6 290 |
|
391 |
Class A antibodies to Trichomonas (Trichomonas vaginalis IgA) |
1 test |
6 290 |
|
392 |
Class G antibodies to Ascaris antigens (Ascaris lumbricoides IgG) |
1 test |
6 290 |
|
393 |
Class G antibodies to Aspergillus antigens (Aspergillus IgG) |
1 test |
6 290 |
|
394 |
Class G antibodies to Opisthorchis antigens (a-Opistorhide IgG) |
1 test |
6 290 |
|
395 |
Class G antibodies to Toxocara antigens (a-Toxocara IgG) |
1 test |
6 290 |
|
396 |
Class G antibodies to Trichinella antigens (a-Trichinella IgG) |
1 test |
6 290 |
|
397 |
Class G antibodies to Echinococcus unilocular antigens (a-Echinococcus IgG) |
1 test |
6 290 |
|
398 |
Class G antibodies to Toxoplasma (Toxoplasma gondii IgG) |
1 test |
6 290 |
|
399 |
Class G antibodies to Trichomonas (Trichomonas vaginalis IgG) |
1 test |
6 290 |
|
400 |
Class A antibodies to Toxoplasma (Toxoplasma gondii IgA) |
1 test |
6 290 |
|
401 |
Class M antibodies to Toxoplasma (Toxoplasma gondii IgM) |
1 test |
6 290 |
|
402 |
Avidity index of class G antibodies to Toxoplasma (Toxoplasma gondii IgG–Avidity) |
1 test |
5 185 |
|
403 |
Specific circulating immunocomplexes (CICs) containing opisthorchis antigens |
1 test |
6 800 |
|
404 |
Total antibodies of class A, M, G to lamblia (a-Lamblia total) |
1 test |
5 355 |
|
Serological markers. Bacterial antibodies |
|||
|
405 |
Class A antibodies to mycoplasma (Mycoplasma hominis IgA) |
1 test |
5 355 |
|
406 |
Class A antibodies to ureaplasma (Ureaplasma urealyticum IgA) |
1 test |
5 355 |
|
407 |
Class G antibodies to ureaplasma (Ureaplasma urealyticum IgG) |
1 test |
5 355 |
|
408 |
Class G antibodies to Helycobacter pylori |
1 test |
6 205 |
|
409 |
Class G antibodies to Chlamydia trachomatis heat shock protein (HSP60), diagnosis of early infection |
1 test |
3 995 |
|
410 |
Class G antibodies to major outer membrane protein (MOMP) and plasmid protein pgp3 of Chlamydia trachomatis |
1 test |
4 675 |
|
411 |
Class G antibodies to mycoplasma (Mycoplasma hominis IgG) |
1 test |
5 355 |
|
412 |
Class G antibodies to chlamydia (Chlamydia trachomatis IgG) |
1 test |
5 355 |
|
413 |
Class M antibodies to chlamydia (Chlamydia trachomatis IgM) |
1 test |
5 355 |
|
414 |
Class A antibodies to chlamydia (Chlamydia trachomatis IgA) |
1 test |
5 355 |
|
415 |
Total antibodies class A, M, G to the Cag antigen of Helycobacter pylori |
1 test |
5 355 |
|
416 |
Total antibodies class A, M, G to Mycobacterium tuberculosis (a-Mycobacterium Tuberculosis) |
1 test |
5 780 |
|
417 |
Total antibodies class A, M, G to syphilis (Treponema pallidum total) |
1 test |
5 780 |
|
Specific blood proteins |
|||
|
418 |
N-terminal pro-brain B-type natriuretic peptide (NT-pro BNP) |
1 test |
29 495 |
|
419 |
Troponin I (TNI), quantitation |
1 test |
13 260 |
|
420 |
Troponin I high sensitivity (TNI), quantitation |
1 test |
15 555 |
|
421 |
Rapid test for the qualitation of Troponin I (TNI) and myoglobin |
1 test |
4 250 |
|
422 |
Brain natriuretic peptide (BNP) |
1 test |
35 700 |
|
|
|||
|
423 |
Neutrophil gelatinase-associated lipocalin, NGAL |
1 test |
11 475 |
|
Microbiological testings |
|||
|
Bacteriological testings |
|||
|
424 |
Bacteriological examination of autopsy material |
1 test |
11 645 |
|
425 |
Bacteriological examination of biomaterial from the nose for staphylococcus |
1 test |
9 860 |
|
426 |
Bacteriological examination of biomaterial for anaerobes |
1 test |
10 200 |
|
427 |
Bacteriological examination of biomaterial for yersiniosis |
1 test |
9 860 |
|
428 |
Bacteriological examination of biomaterial for meningococcus |
1 test |
12 495 |
|
429 |
Bacteriological examination of biomaterial for microflora |
1 test |
16 065 |
|
430 |
Bacteriological examination of biomaterial for the presence of the causative agent of diphtheria |
1 test |
11 645 |
|
431 |
Bacteriological examination of biomaterial for the presence of fungi with identification of their species |
1 test |
11 305 |
|
432 |
Bacteriological examination of stool for cholera (form 30) |
1 test |
11 645 |
|
433 |
Bacteriological blood test for sterility using a bacteriological analyzer |
1 test |
15 045 |
|
434 |
Bacteriological test for group B streptococcus (GBS) |
1 test |
25 925 |
|
435 |
Taking biomaterial for microbiological research |
1 test |
2 210 |
|
436 |
Test for intestinal dysbiosis |
1 test |
24 990 |
|
437 |
Bacteriological examination of feces for pathogenic and opportunistic intestinal microflora with sensitivity determination |
1 test |
9 350 |
|
438 |
Identification of a pure culture of a microorganism using mass spectrometry |
1 test |
3 825 |
|
439 |
Bacteriological examination of biomaterial for meningococcus PASTOREX MENINGITIS |
1 test |
39 270 |
|
440 |
Bacteriological examination of genital secretions using the Genital SYSTEM method |
1 test |
26 775 |
|
441 |
Gene-Xpert Determination of M. tuberculosis and rifampicin resistance |
1 test |
66 045 |
|
Sanitary and bacteriological testings |
|||
|
442 |
Bacteriological air testing (1 room) |
1 test |
3 825 |
|
443 |
Bacteriological examination of liquid dosage forms and material for sterility (10 samples) |
1 test |
5 950 |
|
444 |
Bacteriological testing swabs from environmental objects for coliform bacteria (coliforms), pathogenic intestinal flora, golden staff |
1 test |
2 720 |
|
Sputum examinations |
|||
|
445 |
Microscopic examination of biomaterial for the presence of acid-fast bacteria (AFB) for suspected tuberculosis |
1 test |
4 335 |
|
Parasitological examination of stool |
|||
|
446 |
Examination of stool for helminth eggs using a fecal parasite concentrator |
1 test |
4 505 |
|
447 |
Examination of stool for protozoa and helminth eggs |
1 test |
2 890 |
|
Serological diagnosis of syphilis |
|||
|
448 |
Microreaction |
1 test |
2 295 |
|
449 |
Wasserman reaction (RW) |
1 test |
6 630 |
|
450 |
Syphilis, Rapid test (Specific antibodies to Treponema pallidum, qualitative determination) |
1 test |
6 120 |
|
Molecular biological research (PCR) |
|||
|
PCR based bacterial infections diagnostics |
|||
|
451 |
Brucella DNA (DNA Brucella species) |
1 test |
8 925 |
|
452 |
DNA of the causative agent of respiratory mycoplasmosis/chlamydia (Mycoplasma pneumoniae/Chlamydophila pneumoniae DNA) |
1 test |
11 135 |
|
453 |
Mycobacterium tuberculosis DNA (Mucobacterium tuberculosis DNA) |
1 test |
6 460 |
|
454 |
Toxoplasma gondii DNA |
1 test |
6 290 |
|
PCR based viral hepatitis diagnostics |
|||
|
455 |
Hepatitis C virus genotyping: 1a, 1b, 2, 3a, 4b genotypes (HCV Genotype, HCV Genotyping/Subtyping) Genotyping/Subtyping) |
1 test |
22 525 |
|
456 |
Hepatitis B virus DNA, qualitaion (HBV DNA Qualitative) |
1 test |
15 215 |
|
457 |
Hepatitis B virus DNA, quantitation (HBV DNA viral load, HBV DNA Quant.) |
1 test |
21 080 |
|
458 |
Hepatitis D virus RNA, qualitation (HDV RNA Qualitative) |
1 test |
17 000 |
|
459 |
Hepatitis C virus RNA quantitation (HCV RNA viral load, HCV RNA Quant.) |
1 test |
23 630 |
|
460 |
Hepatitis C virus RNA, qualitation (HCV RNA, RNA HCV Qualitative) |
1 test |
16 660 |
|
PCR based viral infections diagnostics |
|||
|
461 |
PCR based diagnostics of the COVID-19 virus |
1 test |
13 430 |
|
462 |
DNA cytomegalovirus (DNA Cytomegalovirus Quant), quantitation) |
1 test |
17 850 |
|
463 |
DNA of Gardnerella and others (Florocenosis/bacterial vaginosis) quantitation |
1 test |
8 415 |
|
464 |
Human papillomavirus DNA of high carcinogenic risk, screening (HPV DNA, high-risk HPV DNA) |
1 test |
18 785 |
|
465 |
Varicella-Zoster virus DNA (VZV DNA, DNA Varicella-Zoster virus, DNA VZV) |
1 test |
4 505 |
|
466 |
DNA Rubella virus (DNA Rubella virus) |
1 test |
4 675 |
|
467 |
Human papillomavirus DNA 16/18 types (HPV DNA 16/18, DNA НРV 16/18) |
1 test |
10 710 |
|
468 |
DNA of herpes simplex virus types 1 and 2 (DNA HSV 1, 2) |
1 test |
10 710 |
|
469 |
Epstein-Barr virus DNA (DNA EBV Qualitative), qualitation |
1 test |
5 355 |
|
470 |
Epstein-Barr virus DNA (EBV DNA, DNA EBV Quant), quantitation) |
1 test |
10 710 |
|
471 |
DNA of ARVI pathogens |
1 test |
11 645 |
|
472 |
DNA cytomegalovirus (DNA Cytomegalovirus) |
1 test |
13 430 |
|
473 |
Detection of the DNA of the causative agent of pertussis |
1 test |
9 350 |
|
474 |
Detection of the DNA of the causative agent of pneumocysosis |
1 test |
8 925 |
|
475 |
Detection of human metapneumovirus RNA and human parainfluenza virus type 2 RNA |
1 test |
23 205 |
|
PCR based urogenital infections diagnostics |
|||
|
476 |
DNA of ureaplasma and mycoplasma (Florocenosis/ureaplasma, mycoplasma) (quantitation) |
1 test |
8 245 |
|
477 |
Candida DNA (Florocenosis/Candida) (quantitation) |
1 test |
8 075 |
|
478 |
Candida albicans DNA |
1 test |
6 630 |
|
479 |
Chlamydia trachomatis DNA |
1 test |
6 630 |
|
480 |
Gardnerella vaginalis DNA |
1 test |
6 630 |
|
481 |
Mycoplasma genitalum DNA |
1 test |
6 630 |
|
482 |
Mycoplasma hominis DNA |
1 test |
6 630 |
|
483 |
Neisseria gonorrhoeae DNA |
1 test |
6 630 |
|
484 |
Trichomonas vaginalis DNA |
1 test |
6 630 |
|
485 |
Ureaplasma species DNA |
1 test |
6 630 |
|
PCR based other infections diagnostics |
|||
|
486 |
DNA of helminthiasis pathogens (Ascaris lumbricoides, Enterobius vermicularis, Opisthorchis felineus, Taenia solium, Diphyllobothrium latum) |
1 test |
13 515 |
|
487 |
DNA from pathogens of protozoal infections (Lamblia Intestinalis Giardia, Blastocystis hominis, Dientamoeba fragilis, Isospora belli, Cryptosporidium parvum, Entamoeba histolytica) |
1 test |
13 515 |
|
General clinical studies |
|||
|
General clinical stool examinations |
|||
|
488 |
Examination of feces for occult blood |
1 test |
3 995 |
|
489 |
Test for Helicobacter pylori antigen (qualitation, rapid test) |
1 test |
7 565 |
|
490 |
Calprotectin (qualitation, rapid test) |
1 test |
11 645 |
|
491 |
Calprotectin (quantitation by enzyme immunoassay) |
1 test |
21 760 |
|
492 |
Coprogram |
1 test |
5 355 |
|
General clinical urine tests |
|||
|
493 |
Protein in daily urine |
1 test |
3 060 |
|
494 |
Urinalysis according to Nechiporenko |
1 test |
3 570 |
|
495 |
Daily urinу analysis according to Zimnitsky |
1 test |
3 570 |
|
496 |
Microalbumin (MAU) in a single portion of urine (semi-quantitative determination) |
1 test |
1 785 |
|
497 |
General sputum analysis |
1 test |
3 570 |
|
498 |
General urinalysis (UCA) |
1 test |
2 550 |
|
499 |
Rhinocytogram (cellular composition) |
1 test |
3 995 |
|
500 |
Three-glass urine sample |
1 test |
2 380 |
|
Сlinical examinations of urethral and vaginal discharge |
|||
|
501 |
Microscopic examination of urethral discharge (urethral smear) |
1 test |
4 165 |
|
502 |
Microscopic examination of prostate secretion (prostate gland) |
1 test |
4 165 |
|
503 |
Determining the degree of purity of a gynecological smear |
1 test |
5 355 |
|
504 |
Spermogram with determination of sperm morphology |
1 test |
15 215 |
|
505 |
MAR test |
1 test |
13 430 |
|
Сlinical examinations of other biomaterial |
|||
|
506 |
Biomaterial examination for the genus Demodex (Demodex) |
1 test |
3 570 |
|
507 |
Biomaterial examination for the pathogenic fungi |
1 test |
3 060 |
|
508 |
Clinical examination of cerebrospinal fluid (CSF, cerebrospinal fluid) |
1 test |
2 210 |
|
509 |
Clinical examination of duodenal contents (bile) |
1 test |
5 015 |
|
510 |
Clinical examination of serous cavities fluids and cysts (exudate, transudate) |
1 test |
2 380 |
|
511 |
Microscopic examination of a smear stained according to Romanovsky |
1 test |
3 400 |
|
512 |
Microscopic examination of skin scrapings for the scabies mites. |
1 test |
3 570 |
|
Genomic laboratory services |
|||
|
513 |
Molecular genetic analysis of mutations, chimeric transcripts and copy number variants in 52 key genes connected with canceration, pan |
1 test |
803 250 |
|
514 |
Molecular genetic analysis of mutations, chimeric transcripts and copy number variants in 69 key genes connected with the development of myeloid disorders |
1 test |
856 800 |
|
515 |
Molecular genetic diagnosis of V600E mutations in the BRAF gene from tumor cells enclosed in paraffin sections |
1 test |
118 660 |
|
516 |
Molecular genetic diagnosis of mutations in the ALK gene from tumor cells enclosed in paraffin sections |
1 test |
80 325 |
|
517 |
Whole exome sequencing of human DNA to search for a presumably hereditary disease with interpretation of the results |
1 test |
1 963 500 |
|
518 |
Mutations in HLA CLASS II genes - DQ2, DQ8, DQA1*05 in celiac disease using real-time PCR |
1 test |
160 650 |
|
519 |
FISH diagnostics of bone marrow cells to identify the chimeric gene BCR/ABL t(9;22), in CML and ALLrh+ |
1 test |
89 420 |
|
520 |
FISH diagnosis of bladder cancer to detect aneuploidy of chromosomes 3, 7, 17 and deletion of the 9p21 locus |
1 test |
132 090 |
|
521 |
FISH diagnosis of numerical chromosomal pathologies 13, 18, 21, X and Y in amniotic fluid |
1 test |
105 315 |
|
522 |
Qualitation of the chimeric gene BCR/ABL-t(9;22) using real-time PCR |
1 test |
28 560 |
|
523 |
Quantitative determination of the BCR/ABL-t(9;22) chimeric gene using real-time PCR |
1 test |
48 195 |
|
524 |
Molecular genetic diagnosis using MLPA method of large deletions/duplications in the SMN1 and SMN2 genes associated with spinal muscular atrophy |
1 test |
125 885 |
|
525 |
Minimal residual disease |
1 test |
48 195 |
|
526 |
Mutation in the DMD gene in Duchenne muscular dystrophy using the MLPA method |
1 test |
125 885 |
|
527 |
Standard cytogenetic research (karyotyping) of peripheral blood cells |
1 test |
53 550 |
|
528 |
Molecular genetic analysis (genotyping) of mutations in genes associated with the risk of arterial hypertension and diabetes mellitus 2 s |
1 test |
106 675 |
|
529 |
Molecular genetic diagnosis of V617F mutations in the JAK2 gene in myeloproliferative diseases |
1 test |
48 195 |
|
530 |
Molecular genetic assessing the ratios of human microorganisms (microbiome) |
1 test |
298 095 |
|
531 |
Molecular genetic prenatal diagnosis of amniotic fluid cells for aneuploidy of chromosomes 13, 18, 21, X, Y |
1 test |
99 960 |
|
532 |
Molecular genetic analysis of mutations in 12 genes associated with epidermolysis bullosa |
1 test |
312 375 |
|
533 |
Molecular genetic analysis of sensitivity to imatinib for patients with the Ph chromosome in CML and ALLPh+ |
1 test |
51 765 |
|
534 |
Molecular genetic diagnosis of polymorphism for susceptibility genes PNPLA3 and TM6SF2 in non-alcoholic steatohepatitis |
1 test |
25 415 |
|
535 |
Mutations in the BRCA gene Oncomine Research Assay |
1 test |
569 415 |
|
536 |
Mutations, chimeric transcripts and copy number variants in 161 genes associated with canceration, ONCOMINE Comprehensive ASSAY panel |
1 test |
785 400 |
|
537 |
Genealogical origin by Y chromosome |
1 test |
140 165 |
|
538 |
Mutations in the FLT3 gene (ITD, TKD - D835F) by molecular genetic method |
1 test |
57 120 |
|
539 |
JAK2 gene mutations in exon 12 by MLPA method (fragment analysis) |
1 test |
80 325 |
|
540 |
Mutation in the PIK3CA gene using a molecular genetic method |
1 test |
80 325 |
|
541 |
Mutations in the CFTR gene in cystic fibrosis |
1 test |
127 670 |
|
542 |
Individual sensitivity to warfarin |
1 test |
66 980 |
|
543 |
Microdeletions (fragment analysis) using the MLPA method for delayed psychomotor development |
1 test |
125 885 |
|
544 |
Genotyping in Amyotrophic Lateral Sclerosis |
1 test |
76 755 |
|
545 |
Mutations in the KRAS gene |
1 test |
180 285 |
|
546 |
Molecular genetic analysis for microsatellite instability (MSI) |
1 test |
203 490 |
|
547 |
Fetal Rh factor in maternal blood |
1 test |
83 045 |
|
548 |
Mutations in freely circulating tumor DNA |
1 test |
1 071 000 |
|
549 |
Mutations in the NF1 gene in neurofibromatosis using the MLPA method |
1 test |
385 560 |
|
550 |
Chimeric gene KIAA-BRAF, BRAF V600E by MLPA |
1 test |
160 650 |
|
551 |
ERBB2 (HER2) gene amplification |
1 test |
142 800 |
|
552 |
Non-invasive prenatal testing for the risk of aneuploidies (chromosomes 13,18,21) |
1 test |
267 750 |
|
553 |
Determination of CD274 (PD-L1) gene amplification |
1 test |
157 080 |
|
554 |
Detection of SMN1 and SMN2 gene mutations using PCR |
1 test |
11 645 |
|
555 |
HPV genotyping by sequencing |
1 test |
107 100 |
|
556 |
Gene sequencing for hereditary diseases using NGS (Next-Generation Sequencing) |
1 test |
749 700 |
|
Gliomas diagnostics |
|||
|
557 |
Detection of aberrant methylation (MGMT) |
1 test |
81 260 |
|
558 |
Detection of mutations in the IDH1 and IDH2 genes |
1 test |
81 260 |
|
559 |
Detection of WNT and SHH pathway activation mutations |
1 test |
111 605 |
|
560 |
Detection of mutations in the CDKN2A/2B genes |
1 test |
81 260 |
|
561 |
Detection of mutations in the EGFR gene |
1 test |
81 260 |
|
562 |
Detection of mutations in the ATRX gene |
1 test |
81 260 |
|
563 |
Detection of mutations in the TP53 gene |
1 test |
81 260 |
|
564 |
Detection of 1p/19q co-expression |
1 test |
81 260 |
|
565 |
Detection of H3K27 mutation |
1 test |
187 425 |
|
566 |
Detection of mutations in the MYCN gene |
1 test |
81 260 |
|
567 |
Detection of RELA fusion mutation |
1 test |
163 370 |
|
568 |
C19MC gene, miRNA profiling |
1 test |
63 410 |
|
569 |
Detection of mutations in the VEGF gene |
1 test |
74 970 |
|
570 |
“Glioma” panel (Mutation status of tumor cells in gliomas |
1 test |
767 550 |
|
571 |
Detection of mutations in the FGFR gene |
1 test |
107 100 |